Cencora, a global pharmaceutical solutions company, announced it has signed a definitive agreement to acquire EyeSouth Partners’ retina business for $1.1 billion, strengthening its position in specialty eye care through its Retina Consultants of America platform.
Upon closing, the affiliated retina physicians from EyeSouth Partners will join Retina Consultants of America, a leading management services organization focused on retina care. The transaction represents a continuation of Cencora’s strategy to expand its specialty healthcare footprint and deepen capabilities in ophthalmology.
The company said the deal is expected to be slightly accretive to adjusted diluted earnings per share within the first twelve months following closing, net of financing costs. The transaction remains subject to customary closing conditions, including regulatory approvals, and is not currently reflected in Cencora’s fiscal 2026 financial guidance.
The acquisition is expected to enhance access to clinical trials, research capabilities, and advanced treatment options for patients, while supporting physicians through Retina Consultants of America’s physician-centered model.
Support: Cencora is working with BofA Securities as lead financial advisor, alongside Citi, with Sidley Austin LLP serving as legal advisor. EyeSouth Partners, a portfolio company of Olympus Partners, is advised by Jefferies LLC and Kirkland & Ellis LLP.
KEY QUOTES:
“Driven by a commitment to empower ophthalmologists, EyeSouth Partners has built a strong regional network of physicians that provides high quality patient care. By joining RCA, these physicians will become part of an organization with capabilities designed to provide world-class retina care and be supported by Cencora’s longstanding commitment to community physicians.”
Robert P. Mauch, President And Chief Executive Officer, Cencora
“We look forward to collaborating with the well-trained and respected EyeSouth Partners’ physicians as we work together to advance sight-saving treatment for patients.”
David Brown, M.D., Chief Medical Officer, Retina Consultants Of America
“We are excited to be joining RCA, which shares our commitment to delivering exceptional care and advancing the fight against blindness. Our physicians will drive expanded access to innovative treatments through RCA’s clinical trial and research offerings while continuing to work with EyeSouth Partners to support patient access across the ophthalmology landscape.”
Atul Sharma, M.D., Board Member, EyeSouth Partners
